Arcutis Biotherapeutics, Inc.ARQTNASDAQ

Revenue (LTM)

$376M

+91.3% YoY

Net Income (LTM)

$-16M

+88.5% YoY

Free Cash Flow

$-6M

Revenue CAGR (5Y)

—

Marginsimproving

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	4	60↑1517.1%	197↑229.7%	376↑91.3%
Gross Profit	-1	3↑484.3%	55↑1762.9%	177↑224.8%	339↑91.3%
Operating Income	-207	-302↓46.0%	-241↑20.1%	-128↑46.7%	-12↑90.5%
Net Income	-206	-311↓50.9%	-262↑15.8%	-140↑46.6%	-16↑88.5%
EBITDA	-206	-295↓43.3%	-227↑22.8%	-110↑51.8%	2↑102.3%
EPS Diluted	-4.17	-5.66↓35.7%	-3.78↑33.2%	-1.16↑69.3%	-0.13↑88.8%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	98	54↓45.3%	88↑64.8%	71↓19.3%	43↓39.9%
Total Current Assets	403	437↑8.6%	330↓24.5%	336↑1.6%	411↑22.5%
Total Assets	408	449↑10.1%	341↓24.0%	349↑2.2%	433↑24.1%
Total Current Liabilities	33	38↑13.4%	47↑23.4%	81↑73.6%	130↑60.3%
Total Liabilities	110	240↑117.0%	253↑5.4%	191↓24.3%	243↑27.3%
Total Equity	298	210↓29.6%	89↓57.7%	158↑77.7%	189↑20.3%
Total Debt	78	203↑161.2%	206↑1.7%	111↓46.3%	6↓94.3%
Net Debt	-20	149↑828.7%	118↓21.1%	39↓66.6%	-37↓193.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-175	-258↓47.6%	-247↑4.1%	-112↑54.6%	-6↑95.0%
Capital Expenditure	-1	-23↓2240.0%	-0↑98.2%	-0↑66.6%	-1↓379.7%
Free Cash Flow	-176	-281↓60.0%	-247↑11.9%	-112↑54.6%	-6↑94.4%
Stock-Based Comp	24	33↑36.8%	39↑18.8%	42↑7.5%	40↓3.3%
Net Change in Cash	31	-43↓237.5%	34↑179.9%	-17↓150.4%	-29↓65.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance